PreciseInhale ® Nebulizer provides a comprehensive solution for aerosol atomization, whether it is dry powder DPIs、pMDIs, Or other liquid aerosols can achieve precise aerosol control and can be applied to various aerosol exposure experiments, such as oral and nasal inhalation, tracheal inhalation, cell toxicity, ex vivo lungs, artificial blood gas barrier research, etc.
PreciseInhale ® Being able to quickly and accurately control aerosol generation, and provide precise and prospective dose data, greatly reducing in vivo or in vitro experimental errors and lowering risks.
Product features:
·Small standard deviation: The typical standard deviation of aerosol data is less than 10%, while traditional methods can even reach up to 100%;
·Low drug consumption: Only 100mg or less of the drug is needed for complete pharmacokinetic experiments, reducing the consumption of precious drugs;
·Quality rather than quantity: In vitro modules can achieve high-precision control of drug dosage for individual animals and provide precise and clear dosage data, saving animal usage;
·Uniform aerosol particles: Both internal and external modules can generate uniform aerosol particles, greatly reducing detection errors and producing comparable data.
Unlike high-pressure injection, PreciseInhale's unique and precise administration method can generate a mild and controllable aerosol flow, enabling continuous control and monitoring of aerosol concentration and respiratory patterns of each animal.
Unique external module
✓ Identify and rank the test drug, compare the generic drug formula with the original drug.
PreciseInhale is an advanced aerosol generation system that can be widely used for precise administration of in vitro and in vivo exposure modules. Aerosols can come from dry powders, various inhalers, or nebulizers:
DissolvIt ® The module is a breakthrough product in the iViVC field, providing highly prospective data on drug solubility and absorption, enabling accurate early identification and ranking of candidate drugs, accelerating drug screening and development processes.
PreciseInhale redefines the 3R standard
Reduce - precise control to reduce animal/drug usage
✓ High precision particle control, uniform distribution of sample particles, only 100mg of drug is needed to complete the complete pharmacokinetic experiment, reducing the amount of precious drugs and saving experimental costs;
reference:
1.Delivering horseradish peroxidase as a respirable powder to the isolated, perfused, and ventilated lung of the rat: the pulmonary disposition of an inhaled model biopharmaceutical;
PreciseInhale ® – Isolated Perfused Lung (IPL)
2.Investigation of Lung Pharmacokinetic of the Novel PDE4 Inhibitor CHF6001 in Preclinical Models: Evaluation of the PreciseInhale Technology;
PreciseInhale ® – Isolated Perfused Lung (IPL)
3.Dry powder inhalation exposures of the endotracheally intubated rat lung, ex vivo and in vivo: the pulmonary pharmacokinetics of fluticasone furoate;
PreciseInhale ® – Isolated Perfused Lung (IPL)
4.In Vitro to ex Vivo/In Vivo Correlation (IVIVC) of dissolution kinetics from inhaled particulate solutes using air/blood barrier models: Relation between in vitro design, lung physiology and kinetic output of models;
DissolvIt ® – Dissolution tests
5.Dry powder inhalation exposures of the endotracheally intubated rat lung, ex vivo and in vivo: the pulmonary pharmacokinetics of fluticasone furoate
PreciseInhale ® – in vivo exposure
:,
:
yuyanbio
: yuyanbio